Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients

Clinical trial NCT05912816 · RECRUITING

Trial details

NCT number: NCT05912816
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Upper Urinary Tract Urothelial Carcinoma Kidney Preservation HER-2 ADC PD-1antibody

Start date: 2023-06-10
Primary completion: 2025-11-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.